Core Viewpoint - The average dividend realization rate for the life insurance industry in 2024 is 61.7%, an increase of 11 percentage points year-on-year, indicating improvements in the management and expectation guidance of participating insurance products [3][4]. Dividend Realization Rate Analysis - As of September 10, 2024, 76 life insurance companies reported 3,357 participating insurance products, with 12 products having a realization rate of zero, 2,726 products (81.2%) below 100%, 256 products (7.6%) achieving 100%, and 363 products (10.8%) exceeding 100% [3][4]. - The realization rate reflects the insurance company's ability to fulfill non-guaranteed dividends, serving as a key indicator of investment management effectiveness and operational transparency [4]. Improving Dividend Realization Rates - The National Financial Regulatory Administration issued a notice on August 2, 2024, emphasizing the need for insurance companies to balance demonstration benefits with realization rates [6]. - The relationship between demonstration benefits and realization rates is crucial, where demonstration benefits are based on hypothetical investment scenarios, while realization rates reflect actual performance [8][9]. - To enhance realization rates, companies must set reasonable demonstration rates and improve investment capabilities, especially for already sold policies [11]. Evaluation Criteria for Life Insurance Companies - Long-term assessment of realization rates should consider historical data, stability of dividend policies, and the company's long-term investment returns [13]. - Companies should maintain a safe solvency margin and healthy risk ratings, focusing on those with stable operations [13]. - Currently, 42 companies meet the criteria set by "13精," with New China Life Insurance leading in average realization rates for 2024 [14]. New China Life Insurance Performance - New China Life Insurance reported an average realization rate of 156.1% over the past five years, ranking first among 27 companies [15]. - In 2024, 80 participating insurance products were disclosed, with 63 products achieving or exceeding a 100% realization rate, reflecting strong investment return capabilities [17]. - The company has shown excellent long-term investment returns, with an average total investment return rate of 5.1% from 2015 to 2024, and total assets reaching 1.78 trillion yuan, indicating robust market validation of its investment capabilities [17][18].

Core Insights - Xinhua Insurance's stock price increased by 2.12% on October 10, reaching 63.07 CNY per share, with a total market capitalization of 196.75 billion CNY [1] - The company has seen a year-to-date stock price increase of 32.19%, with a 6.48% rise over the past five trading days [1] Financial Performance - For the first half of 2025, Xinhua Insurance reported a net profit of 14.799 billion CNY, representing a year-on-year growth of 33.53% [2] - The company had zero operating revenue for the same period [2] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 15.88% to 61,000, while the average number of circulating shares per person increased by 18.96% to 34,325 shares [2] - Cumulative cash dividends since the A-share listing amount to 35.939 billion CNY, with 13.913 billion CNY distributed over the last three years [3] Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited is the fourth-largest circulating shareholder, holding 60.5095 million shares, an increase of 6.6977 million shares from the previous period [3] - Huatai-PB CSI 300 ETF is the tenth-largest circulating shareholder, holding 14.9041 million shares, up by 1.1914 million shares [3]

Core Viewpoint - The release of the "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" by the China Banking and Insurance Regulatory Commission (CBIRC) is expected to benefit the long-term development of health insurance, improving the investment ecology for insurance funds in a persistently low interest rate environment. The implementation of new standards is anticipated to enhance the profitability elasticity of insurance companies as stock holdings increase [1][2]. Group 1: Policy Highlights - The policy supports the development of dividend-type long-term health insurance, allowing well-rated insurance companies to engage in this business, which has seen improvements in pricing standards and consumer protection [3]. - The introduction of "personal account-style long-term medical insurance" emphasizes the accumulation of personal funds to cover out-of-pocket expenses, aiming to alleviate financial pressure on residents' medical insurance funds [4]. - The policy encourages the development of commercial insurance payment functions to reduce the burden on basic medical insurance and support the innovation of drugs and medical devices [5]. Group 2: Industry Development Opportunities - The policy promotes data sharing and collaboration across industries to enhance the efficiency of commercial health insurance claims [6]. - Support is provided for health insurance companies to integrate health management services into their products, potentially creating a competitive advantage in the market [7][8]. - New opportunities are anticipated for long-term care insurance, with provisions for converting life insurance benefits into care expenses and addressing various care needs [9].

A 股证券代码：601336 A 股证券简称：新华保险 公告编号：2025-054 号 H 股证券代码： 01336 H 股证券简称：新华保险 新华人寿保险股份有限公司 关于召开 2025 年第三次临时股东大会的通知 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任 何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整 性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025 年第三次临时股东大会（以下简称"本次股东大会"或"股东大会"） 股东大会召开日期：2025年10月31日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：新华人寿保险股份有限公司（以下简称"本公司"或 "公司"）董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 10 月 31 日 14 点 30 分 召开地点：北京市朝阳区建国门外大街甲 12 号新华保险大厦 21 层 (五) 网络投票的系统、起止日期和投票时间。 ...

Core Viewpoint - The article discusses the analysis of the embedded value changes of listed life insurance companies for the first half of 2025, highlighting a 7.7% growth in embedded value, driven by various factors including expected returns and new business value creation [2][14]. Summary by Sections Embedded Value Changes - The embedded value of listed life insurance companies increased by 7.7% in the first half of 2025, with the expected return on the initial embedded value contributing 2.8%, new business value creation contributing 2.6%, investment return differences contributing 1.4%, and operational experience deviations contributing 0.83% [14][26]. ROEV Analysis - The overall Return on Embedded Value (ROEV) for listed life insurance companies was 6.3%, a decrease of 0.5 percentage points year-on-year. Companies like China Life, Ping An Life, and Taiping Life saw a decline in ROEV, while New China Life, AIA, and Sunshine Life experienced improvements [29][30]. Factors Influencing Embedded Value - The factors influencing the embedded value changes are ranked as follows: expected return on embedded value, new business value creation, investment return differences, operational experience deviations, and changes in assumptions and models [16][18]. Detailed Breakdown of Influencing Factors - **Expected Return on Embedded Value**: Averaged 2.8%, down 0.5 percentage points year-on-year, with most companies (except AIA) showing a decline [18]. - **New Business Value Creation**: Contributed 2.56%, down 0.2 percentage points year-on-year, with some companies like Ping An Life and New China Life showing improvements while others declined [18]. - **Operational Experience Deviations**: Averaged 0.83%, up 0.1 percentage points year-on-year, indicating positive impacts from actual operational experiences [23]. - **Investment Return Differences**: Averaged 1.4%, up 0.5 percentage points year-on-year, with most companies reporting positive deviations [26]. Company-Specific Insights - Sunshine Life reported the highest ROEV at 11.1%, followed by AIA at 8.6% and Ping An Life at 7.5% [30].

智通财经APP讯，新华保险(01336)发布公告，该公司将于2025年12月12日派发中期股息每股0.67元人民 币。 ...

新华保险（601336）(01336)发布公告，该公司将于2025年12月12日派发中期股息每股0.67元人民币。 ...

新华人寿保险股份有限公司 2025 年第三次临时股东大会 会议材料 二〇二五年十月九日 北京 1/39 新华人寿保险股份有限公司 2025 年第三次临时股东大会议程 会 议 时 间 ：2025 年 10 月 31 日（星期五）下午 14 点 30 分 会 议 地 点 ：北京市朝阳区建国门外大街甲 12 号新华保险大厦 21 层 会议召集人：新华人寿保险股份有限公司董事会 一、宣布会议开始及会议议程 二、审议议案 （一）普通决议事项 1. 关于 2025 年度中期利润分配方案的议案 （二）特别决议事项 2. 关于修订《公司章程》及撤销监事会的议案 3. 关于修订《股东大会议事规则》的议案 4. 关于修订《董事会议事规则》的议案 三、回答股东提问 四、宣布出席会议股东及股东代理人人数、代表股份数 六、休会、统计现场表决结果 七、宣布现场表决结果 议案一 关于 2025 年度中期利润分配方案的议案 各位股东： 经德勤华永会计师事务所（特殊普通合伙）审阅，公司 2025 年中期母公 司财务报表净利润为 143.33 亿元（人民币，下同），合并财务报表归属于母公 司股东的净利润为 147.99 亿元。截至 2025 年 ...

EF001 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 於本公告日期，本公司董事長、執行董事為楊玉成；執行董事為龔興峰；非執行董事為楊雪、毛思雪、胡愛民和張曉東；及獨立非 執行董事為馬耀添、賴觀榮、徐徐、郭永清和卓志。 第 2 頁 共 2 頁 v 1.1.1 第 1 頁 共 2 頁 v 1.1.1 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 新華人壽保險股份有限公司 | | 股份代號 | 01336 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至二零二五年六月三十日止六個月的中期股息（更新） | | 公告日期 | 2025年10月9日 | | 公告狀態 | 更新公告 | | 更新/撤回理由 | ...

NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 2025年10月31日舉行之2025年第三次臨時股東大會適用之 代表委任表格 | 與本代表委任表格 | | --- | | 有關之H股股份數目1 | 本人╱吾等2 ， 地址為 ， 為新華人壽保險股份有限公司（「本公司」）股本中每股面值人民幣1.00元之H股 股 之登記股東，茲委任3 地址為 | | 普通決議案 | 贊成4 | 反對4 | 棄權4 | | --- | --- | --- | --- | --- | | 1. | 審議及批准關於2025年度中期利潤分配方案的議案 | | | | | | 特別決議案 | 贊成4 | 反對4 | 棄權4 | | 2. | 審議及批准關於修訂《公司章程》及撤銷監事會的議案 | | | | | 3. | 審議及批准關於修訂《股東大會議事規則》的議案 | | | | | 4. | 審議及批准關於修訂《董事會議事規則》的議案 | | | | 日期： 年 月 日 簽署5 附註： 1 請填上以 閣下名義登記的與本代表委任表格有關的H股股份數目。如填上數目，則本代表委任表格將被 視為僅與該等H股 ...